img

Global Typhoid Vaccine Industry Research Report, Growth Trends and Competitive Analysis 2024-2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Typhoid Vaccine Industry Research Report, Growth Trends and Competitive Analysis 2024-2034

The global Typhoid Vaccine market size was US$ million in 2022 and is forecast to a readjusted size of US$ million by 2034 with a CAGR of % during the forecast period 2024-2034.
The United States market for Typhoid Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The China market for Typhoid Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The Europe market for Typhoid Vaccine is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034..
The global key manufacturers of Typhoid Vaccine include Sanofi, Merck, GlaxoSmithKline, PaxVax, Actiza Pharmaceutical, Merit Pharmaceuticals and Bharat Biotec, etc. In 2022, the global top five players hold a share approximately % in sales volume, and in term of revenue of Typhoid Vaccine, the top five companies hold a share nearly %.
In terms of sales (consumption) side, this report focuses on the sales of Typhoid Vaccine by regions (Countries), company, by type and by type. from 2018 to 2024 and forecast to 2034.
The global Typhoid Vaccine market is thoroughly, accurately, and comprehensively assessed in the report with a large focus on market dynamics, market competition, regional growth, segmental analysis, and key growth strategies. Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of sales analysis, the authors of the report have provided reliable estimations and calculations for global revenue and sales by type segment of the global Typhoid Vaccine market. These figures have been provided in terms of both revenue and sales for the period 2018-2034. Additionally, the report provides accurate figures for sales by region in terms of revenue as well as volume for the same period.



By Company


Sanofi
Merck
GlaxoSmithKline
PaxVax
Actiza Pharmaceutical
Merit Pharmaceuticals
Bharat Biotec
By Type
Oral Type Typhoid Vaccine
Injection Type Typhoid Vaccine
By Application
Hospital
Research & Academic Laboratories
Pharmaceutical & Biotechnology Companies
Others
Sales by Region
North America
U.S.
Canada
China
APAC (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Middle East, Africa, Latin America
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2Sales (consumption), revenue of Typhoid Vaccine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3Detailed analysis of Typhoid Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6North America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 7Europe by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 8China by company, by type and by application, sales, and revenue for each segment.
Chapter 9APAC (excluding China) by company, by type, by application and by region, sales, and revenue for each segment.
Chapter 10Middle East, Africa, and Latin America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 11Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Typhoid Vaccine sales, revenue, price, gross margin, and recent development, etc.
Chapter 12Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14The main points and conclusions of the report.

Table of Content

1 Report Overview
1.1 Typhoid Vaccine Definition
1.2 Market by Type
1.2.1 Global Typhoid Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2034
1.2.2 Oral Type Typhoid Vaccine
1.2.3 Injection Type Typhoid Vaccine
1.3 Market Segment by Application
1.3.1 Global Typhoid Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2034
1.3.2 Hospital
1.3.3 Research & Academic Laboratories
1.3.4 Pharmaceutical & Biotechnology Companies
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Typhoid Vaccine Sales
2.1 Global Typhoid Vaccine Revenue Estimates and Forecasts 2018-2034
2.2 Global Typhoid Vaccine Revenue by Region: 2018 VS 2022 VS 2034
2.3 Global Typhoid Vaccine Revenue by Region
2.3.1 Global Typhoid Vaccine Revenue by Region (2018-2024)
2.3.2 Global Typhoid Vaccine Revenue by Region (2024-2034)
2.4 Global Typhoid Vaccine Sales Quantity Estimates and Forecasts 2018-2034
2.5 Global Typhoid Vaccine Sales Quantity by Region: 2018 VS 2022 VS 2034
2.6 Global Typhoid Vaccine Sales Quantity by Region
2.6.1 Global Typhoid Vaccine Sales Quantity by Region (2018-2024)
2.6.2 Global Typhoid Vaccine Sales Quantity by Region (2024-2034)
2.7 North America
2.8 Europe
2.9 China
2.10 APAC (excluding China)
2.11 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Typhoid Vaccine Sales Quantity by Manufacturers
3.1.1 Global Typhoid Vaccine Sales Quantity by Manufacturers (2018-2024)
3.1.2 Global Typhoid Vaccine Sales Quantity Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Companies by Typhoid Vaccine Sales in 2022
3.2 Global Typhoid Vaccine Revenue by Manufacturers
3.2.1 Global Typhoid Vaccine Revenue by Manufacturers (2018-2024)
3.2.2 Global Typhoid Vaccine Revenue Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Typhoid Vaccine Revenue in 2022
3.3 Global Typhoid Vaccine Sales Price by Manufacturers
3.4 Global Key Players of Typhoid Vaccine, Industry Ranking, 2021 VS 2022
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Typhoid Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Typhoid Vaccine, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Typhoid Vaccine, Product Offered and Application
3.8 Global Key Manufacturers of Typhoid Vaccine, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Estimates and Forecasts by Type
4.1 Global Typhoid Vaccine Sales Quantity by Type
4.1.1 Global Typhoid Vaccine Historical Sales Quantity by Type (2018-2024)
4.1.2 Global Typhoid Vaccine Forecasted Sales Quantity by Type (2024-2034)
4.1.3 Global Typhoid Vaccine Sales Quantity Market Share by Type (2018-2034)
4.2 Global Typhoid Vaccine Revenue by Type
4.2.1 Global Typhoid Vaccine Historical Revenue by Type (2018-2024)
4.2.2 Global Typhoid Vaccine Forecasted Revenue by Type (2024-2034)
4.2.3 Global Typhoid Vaccine Revenue Market Share by Type (2018-2034)
4.3 Global Typhoid Vaccine Price by Type
4.3.1 Global Typhoid Vaccine Price by Type (2018-2024)
4.3.2 Global Typhoid Vaccine Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global Typhoid Vaccine Sales Quantity by Application
5.1.1 Global Typhoid Vaccine Historical Sales Quantity by Application (2018-2024)
5.1.2 Global Typhoid Vaccine Forecasted Sales Quantity by Application (2024-2034)
5.1.3 Global Typhoid Vaccine Sales Quantity Market Share by Application (2018-2034)
5.2 Global Typhoid Vaccine Revenue by Application
5.2.1 Global Typhoid Vaccine Historical Revenue by Application (2018-2024)
5.2.2 Global Typhoid Vaccine Forecasted Revenue by Application (2024-2034)
5.2.3 Global Typhoid Vaccine Revenue Market Share by Application (2018-2034)
5.3 Global Typhoid Vaccine Price by Application
5.3.1 Global Typhoid Vaccine Price by Application (2018-2024)
5.3.2 Global Typhoid Vaccine Price Forecast by Application (2024-2034)
6 North America
6.1 North America Typhoid Vaccine Sales by Company
6.1.1 North America Typhoid Vaccine Revenue by Company (2018-2024)
6.1.2 North America Typhoid Vaccine Sales Quantity by Company (2018-2024)
6.2 North America Typhoid Vaccine Market Size by Type
6.2.1 North America Typhoid Vaccine Sales Quantity by Type (2018-2034)
6.2.2 North America Typhoid Vaccine Revenue by Type (2018-2034)
6.3 North America Typhoid Vaccine Market Size by Application
6.3.1 North America Typhoid Vaccine Sales Quantity by Application (2018-2034)
6.3.2 North America Typhoid Vaccine Revenue by Application (2018-2034)
6.4 North America Typhoid Vaccine Market Size by Country
6.4.1 North America Typhoid Vaccine Revenue by Country: 2018 VS 2022 VS 2034
6.4.2 North America Typhoid Vaccine Revenue by Country (2018-2034)
6.4.3 North America Typhoid Vaccine Sales Quantity by Country (2018-2034)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Typhoid Vaccine Sales by Company
7.1.1 Europe Typhoid Vaccine Sales Quantity by Company (2018-2024)
7.1.2 Europe Typhoid Vaccine Revenue by Company (2018-2024)
7.2 Europe Typhoid Vaccine Market Size by Type
7.2.1 Europe Typhoid Vaccine Sales Quantity by Type (2018-2034)
7.2.2 Europe Typhoid Vaccine Revenue by Type (2018-2034)
7.3 Europe Typhoid Vaccine Market Size by Application
7.3.1 Europe Typhoid Vaccine Sales Quantity by Application (2018-2034)
7.3.2 Europe Typhoid Vaccine Revenue by Application (2018-2034)
7.4 Europe Typhoid Vaccine Market Size by Country
7.4.1 Europe Typhoid Vaccine Revenue by Country: 2018 VS 2022 VS 2034
7.4.2 Europe Typhoid Vaccine Revenue by Country (2018-2034)
7.4.3 Europe Typhoid Vaccine Sales Quantity by Country (2018-2034)
7.4.4 Germany
7.4.5 France
7.4.6 U.K.
7.4.7 Italy
7.4.8 Russia
8 China
8.1 China Typhoid Vaccine Sales by Company
8.1.1 China Typhoid Vaccine Sales Quantity by Company (2018-2024)
8.1.2 China Typhoid Vaccine Revenue by Company (2018-2024)
8.2 China Typhoid Vaccine Market Size by Type
8.2.1 China Typhoid Vaccine Sales Quantity by Type (2018-2034)
8.2.2 China Typhoid Vaccine Revenue by Type (2018-2034)
8.3 China Typhoid Vaccine Market Size by Application
8.3.1 China Typhoid Vaccine Sales Quantity by Application (2018-2034)
8.3.2 China Typhoid Vaccine Revenue by Application (2018-2034)
9 APAC (excluding China)
9.1 APAC Typhoid Vaccine Sales by Company
9.1.1 APAC Typhoid Vaccine Sales Quantity by Company (2018-2024)
9.1.2 APAC Typhoid Vaccine Revenue by Company (2018-2024)
9.2 APAC Typhoid Vaccine Market Size by Type
9.2.1 APAC Typhoid Vaccine Sales Quantity by Type (2018-2034)
9.2.2 APAC Typhoid Vaccine Revenue by Type (2018-2034)
9.3 APAC Typhoid Vaccine Market Size by Application
9.3.1 APAC Typhoid Vaccine Sales Quantity by Application (2018-2034)
9.3.2 APAC Typhoid Vaccine Revenue by Application (2018-2034)
9.4 APAC Typhoid Vaccine Market Size by Region
9.4.1 APAC Typhoid Vaccine Revenue by Region: 2018 VS 2022 VS 2034
9.4.2 APAC Typhoid Vaccine Revenue by Region (2018-2034)
9.4.3 APAC Typhoid Vaccine Sales Quantity by Region (2018-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Typhoid Vaccine Sales by Company
10.1.1 Middle East, Africa and Latin America Typhoid Vaccine Sales Quantity by Company (2018-2024)
10.1.2 Middle East, Africa and Latin America Typhoid Vaccine Revenue by Company (2018-2024)
10.2 Middle East, Africa and Latin America Typhoid Vaccine Market Size by Type
10.2.1 Middle East, Africa and Latin America Typhoid Vaccine Sales Quantity by Type (2018-2034)
10.2.2 Middle East, Africa and Latin America Typhoid Vaccine Revenue by Type (2018-2034)
10.3 Middle East, Africa and Latin America Typhoid Vaccine Market Size by Application
10.3.1 Middle East, Africa and Latin America Typhoid Vaccine Sales Quantity by Application (2018-2034)
10.3.2 Middle East, Africa and Latin America Typhoid Vaccine Revenue by Application (2018-2034)
10.4 Middle East, Africa and Latin America Typhoid Vaccine Market Size by Country
10.4.1 Middle East, Africa and Latin America Typhoid Vaccine Revenue by Country: 2018 VS 2022 VS 2034
10.4.2 Middle East, Africa and Latin America Typhoid Vaccine Revenue by Country (2018-2034)
10.4.3 Middle East, Africa and Latin America Typhoid Vaccine Sales Quantity by Country (2018-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Israel
10.4.8 GCC Countries
11 Company Profiles
11.1 Sanofi
11.1.1 Sanofi Company Information
11.1.2 Sanofi Overview
11.1.3 Sanofi Typhoid Vaccine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.1.4 Sanofi Typhoid Vaccine Products and Services
11.1.5 Sanofi Typhoid Vaccine SWOT Analysis
11.1.6 Sanofi Recent Developments
11.2 Merck
11.2.1 Merck Company Information
11.2.2 Merck Overview
11.2.3 Merck Typhoid Vaccine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.2.4 Merck Typhoid Vaccine Products and Services
11.2.5 Merck Typhoid Vaccine SWOT Analysis
11.2.6 Merck Recent Developments
11.3 GlaxoSmithKline
11.3.1 GlaxoSmithKline Company Information
11.3.2 GlaxoSmithKline Overview
11.3.3 GlaxoSmithKline Typhoid Vaccine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.3.4 GlaxoSmithKline Typhoid Vaccine Products and Services
11.3.5 GlaxoSmithKline Typhoid Vaccine SWOT Analysis
11.3.6 GlaxoSmithKline Recent Developments
11.4 PaxVax
11.4.1 PaxVax Company Information
11.4.2 PaxVax Overview
11.4.3 PaxVax Typhoid Vaccine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.4.4 PaxVax Typhoid Vaccine Products and Services
11.4.5 PaxVax Typhoid Vaccine SWOT Analysis
11.4.6 PaxVax Recent Developments
11.5 Actiza Pharmaceutical
11.5.1 Actiza Pharmaceutical Company Information
11.5.2 Actiza Pharmaceutical Overview
11.5.3 Actiza Pharmaceutical Typhoid Vaccine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.5.4 Actiza Pharmaceutical Typhoid Vaccine Products and Services
11.5.5 Actiza Pharmaceutical Typhoid Vaccine SWOT Analysis
11.5.6 Actiza Pharmaceutical Recent Developments
11.6 Merit Pharmaceuticals
11.6.1 Merit Pharmaceuticals Company Information
11.6.2 Merit Pharmaceuticals Overview
11.6.3 Merit Pharmaceuticals Typhoid Vaccine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.6.4 Merit Pharmaceuticals Typhoid Vaccine Products and Services
11.6.5 Merit Pharmaceuticals Typhoid Vaccine SWOT Analysis
11.6.6 Merit Pharmaceuticals Recent Developments
11.7 Bharat Biotec
11.7.1 Bharat Biotec Company Information
11.7.2 Bharat Biotec Overview
11.7.3 Bharat Biotec Typhoid Vaccine Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.7.4 Bharat Biotec Typhoid Vaccine Products and Services
11.7.5 Bharat Biotec Typhoid Vaccine SWOT Analysis
11.7.6 Bharat Biotec Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Typhoid Vaccine Value Chain Analysis
12.2 Typhoid Vaccine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Typhoid Vaccine Production Mode & Process
12.4 Typhoid Vaccine Sales and Marketing
12.4.1 Typhoid Vaccine Sales Channels
12.4.2 Typhoid Vaccine Distributors
12.5 Typhoid Vaccine Customers
13 Market Dynamics
13.1 Typhoid Vaccine Industry Trends
13.2 Typhoid Vaccine Market Drivers
13.3 Typhoid Vaccine Market Challenges
13.4 Typhoid Vaccine Market Restraints
14 Key Findings
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Typhoid Vaccine Market Size Growth Rate (CAGR) by Type, 2018 VS 2022 VS 2034 (US$ Million)
Table 2. Major Manufacturers of Oral Type Typhoid Vaccine
Table 3. Major Manufacturers of Injection Type Typhoid Vaccine
Table 4. Global Typhoid Vaccine Market Size Growth Rate (CAGR) by Application, 2018 VS 2022 VS 2034 (US$ Million)
Table 5. Global Typhoid Vaccine Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 6. Global Typhoid Vaccine Revenue by Region (2018-2024) & (US$ Million)
Table 7. Global Typhoid Vaccine Revenue Market Share by Region (2018-2024)
Table 8. Global Typhoid Vaccine Revenue by Region (2024-2034) & (US$ Million)
Table 9. Global Typhoid Vaccine Revenue Market Share by Region (2024-2034)
Table 10. Global Typhoid Vaccine Sales Quantity by Region: 2018 VS 2022 VS 2034 (K Units)
Table 11. Global Typhoid Vaccine Sales by Region (2018-2024) & (K Units)
Table 12. Global Typhoid Vaccine Sales Market Share by Region (2018-2024)
Table 13. Global Typhoid Vaccine Sales by Region (2024-2034) & (K Units)
Table 14. Global Typhoid Vaccine Sales Market Share by Region (2024-2034)
Table 15. Global Typhoid Vaccine Sales Quantity by Manufacturers (2018-2024) & (K Units)
Table 16. Global Typhoid Vaccine Sales Quantity Share by Manufacturers (2018-2024)
Table 17. Global Typhoid Vaccine Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 18. Global Typhoid Vaccine Revenue Share by Manufacturers (2018-2024)
Table 19. Global Typhoid Vaccine Price by Manufacturers 2018-2024 (USD/Unit)
Table 20. Global Key Players of Typhoid Vaccine, Industry Ranking, 2021 VS 2022
Table 21. Global Typhoid Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Typhoid Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Typhoid Vaccine as of 2022)
Table 23. Global Key Manufacturers of Typhoid Vaccine, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Typhoid Vaccine, Product Offered and Application
Table 25. Global Key Manufacturers of Typhoid Vaccine, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Typhoid Vaccine Sales Quantity by Type (2018-2024) & (K Units)
Table 28. Global Typhoid Vaccine Sales Quantity by Type (2024-2034) & (K Units)
Table 29. Global Typhoid Vaccine Sales Quantity Share by Type (2018-2024)
Table 30. Global Typhoid Vaccine Sales Quantity Share by Type (2024-2034)
Table 31. Global Typhoid Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 32. Global Typhoid Vaccine Revenue by Type (2024-2034) & (US$ Million)
Table 33. Global Typhoid Vaccine Revenue Share by Type (2018-2024)
Table 34. Global Typhoid Vaccine Revenue Share by Type (2024-2034)
Table 35. Typhoid Vaccine Price by Type (2018-2024) & (USD/Unit)
Table 36. Global Typhoid Vaccine Price Forecast by Type (2024-2034) & (USD/Unit)
Table 37. Global Typhoid Vaccine Sales Quantity by Application (2018-2024) & (K Units)
Table 38. Global Typhoid Vaccine Sales Quantity by Application (2024-2034) & (K Units)
Table 39. Global Typhoid Vaccine Sales Quantity Share by Application (2018-2024)
Table 40. Global Typhoid Vaccine Sales Quantity Share by Application (2024-2034)
Table 41. Global Typhoid Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 42. Global Typhoid Vaccine Revenue by Application (2024-2034) & (US$ Million)
Table 43. Global Typhoid Vaccine Revenue Share by Application (2018-2024)
Table 44. Global Typhoid Vaccine Revenue Share by Application (2024-2034)
Table 45. Typhoid Vaccine Price by Application (2018-2024) & (USD/Unit)
Table 46. Global Typhoid Vaccine Price Forecast by Application (2024-2034) & (USD/Unit)
Table 47. North America Typhoid Vaccine Revenue by Company (2018-2024) & (US$ Million)
Table 48. North America Typhoid Vaccine Sales Quantity by Company (2018-2024) & (K Units)
Table 49. North America Typhoid Vaccine Sales Quantity by Type (2018-2024) & (K Units)
Table 50. North America Typhoid Vaccine Sales Quantity by Type (2024-2034) & (K Units)
Table 51. North America Typhoid Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 52. North America Typhoid Vaccine Revenue by Type (2024-2034) & (US$ Million)
Table 53. North America Typhoid Vaccine Sales Quantity by Application (2018-2024) & (K Units)
Table 54. North America Typhoid Vaccine Sales Quantity by Application (2024-2034) & (K Units)
Table 55. North America Typhoid Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 56. North America Typhoid Vaccine Revenue by Application (2024-2034) & (US$ Million)
Table 57. North America Typhoid Vaccine Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 58. North America Typhoid Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 59. North America Typhoid Vaccine Revenue by Country (2024-2034) & (US$ Million)
Table 60. North America Typhoid Vaccine Sales Quantity by Country (2018-2024) & (K Units)
Table 61. North America Typhoid Vaccine Sales Quantity by Country (2024-2034) & (K Units)
Table 62. Europe Typhoid Vaccine Sales Quantity by Company (2018-2024) & (K Units)
Table 63. Europe Typhoid Vaccine Revenue by Company (2018-2024) & (US$ Million)
Table 64. Europe Typhoid Vaccine Sales Quantity by Type (2018-2024) & (K Units)
Table 65. Europe Typhoid Vaccine Sales Quantity by Type (2024-2034) & (K Units)
Table 66. Europe Typhoid Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 67. Europe Typhoid Vaccine Revenue by Type (2024-2034) & (US$ Million)
Table 68. Europe Typhoid Vaccine Sales Quantity by Application (2018-2024) & (K Units)
Table 69. Europe Typhoid Vaccine Sales Quantity by Application (2024-2034) & (K Units)
Table 70. Europe Typhoid Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 71. Europe Typhoid Vaccine Revenue by Application (2024-2034) & (US$ Million)
Table 72. Europe Typhoid Vaccine Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 73. Europe Typhoid Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 74. Europe Typhoid Vaccine Revenue by Country (2024-2034) & (US$ Million)
Table 75. Europe Typhoid Vaccine Sales Quantity by Country (2018-2024) & (K Units)
Table 76. Europe Typhoid Vaccine Sales Quantity by Country (2024-2034) & (K Units)
Table 77. China Typhoid Vaccine Sales Quantity by Company (2018-2024) & (K Units)
Table 78. China Typhoid Vaccine Revenue by Company (2018-2024) & (US$ Million)
Table 79. China Typhoid Vaccine Sales Quantity by Type (2018-2024) & (K Units)
Table 80. China Typhoid Vaccine Sales Quantity by Type (2024-2034) & (K Units)
Table 81. China Typhoid Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 82. China Typhoid Vaccine Revenue by Type (2024-2034) & (US$ Million)
Table 83. China Typhoid Vaccine Sales Quantity by Application (2018-2024) & (K Units)
Table 84. China Typhoid Vaccine Sales Quantity by Application (2024-2034) & (K Units)
Table 85. China Typhoid Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 86. China Typhoid Vaccine Revenue by Application (2024-2034) & (US$ Million)
Table 87. APAC Typhoid Vaccine Sales Quantity by Company (2018-2024) & (K Units)
Table 88. APAC Typhoid Vaccine Revenue by Company (2018-2024) & (US$ Million)
Table 89. APAC Typhoid Vaccine Sales Quantity by Type (2018-2024) & (K Units)
Table 90. APAC Typhoid Vaccine Sales Quantity by Type (2024-2034) & (K Units)
Table 91. APAC Typhoid Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 92. APAC Typhoid Vaccine Revenue by Type (2024-2034) & (US$ Million)
Table 93. APAC Typhoid Vaccine Sales Quantity by Application (2018-2024) & (K Units)
Table 94. APAC Typhoid Vaccine Sales Quantity by Application (2024-2034) & (K Units)
Table 95. APAC Typhoid Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 96. APAC Typhoid Vaccine Revenue by Application (2024-2034) & (US$ Million)
Table 97. APAC Typhoid Vaccine Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 98. APAC Typhoid Vaccine Revenue by Region (2018-2024) & (US$ Million)
Table 99. APAC Typhoid Vaccine Revenue by Region (2024-2034) & (US$ Million)
Table 100. APAC Typhoid Vaccine Sales Quantity by Region (2018-2024) & (K Units)
Table 101. APAC Typhoid Vaccine Sales Quantity by Region (2024-2034) & (K Units)
Table 102. Middle East, Africa and Latin America Typhoid Vaccine Sales Quantity by Company (2018-2024) & (K Units)
Table 103. Middle East, Africa and Latin America Typhoid Vaccine Revenue by Company (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Typhoid Vaccine Sales Quantity by Type (2018-2024) & (K Units)
Table 105. Middle East, Africa and Latin America Typhoid Vaccine Sales Quantity by Type (2024-2034) & (K Units)
Table 106. Middle East, Africa and Latin America Typhoid Vaccine Revenue by Type (2018-2024) & (US$ Million)
Table 107. Middle East, Africa and Latin America Typhoid Vaccine Revenue by Type (2024-2034) & (US$ Million)
Table 108. Middle East, Africa and Latin America Typhoid Vaccine Sales Quantity by Application (2018-2024) & (K Units)
Table 109. Middle East, Africa and Latin America Typhoid Vaccine Sales Quantity by Application (2024-2034) & (K Units)
Table 110. Middle East, Africa and Latin America Typhoid Vaccine Revenue by Application (2018-2024) & (US$ Million)
Table 111. Middle East, Africa and Latin America Typhoid Vaccine Revenue by Application (2024-2034) & (US$ Million)
Table 112. Middle East, Africa and Latin America Typhoid Vaccine Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 113. Middle East, Africa and Latin America Typhoid Vaccine Revenue by Country (2018-2024) & (US$ Million)
Table 114. Middle East, Africa and Latin America Typhoid Vaccine Revenue by Country (2024-2034) & (US$ Million)
Table 115. Middle East, Africa and Latin America Typhoid Vaccine Sales Quantity by Country (2018-2024) & (K Units)
Table 116. Middle East, Africa and Latin America Typhoid Vaccine Sales Quantity by Country (2024-2034) & (K Units)
Table 117. Sanofi Company Information
Table 118. Sanofi Description and Overview
Table 119. Sanofi Typhoid Vaccine Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 120. Sanofi Typhoid Vaccine Product and Services
Table 121. Sanofi Typhoid Vaccine SWOT Analysis
Table 122. Sanofi Recent Developments
Table 123. Merck Company Information
Table 124. Merck Description and Overview
Table 125. Merck Typhoid Vaccine Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 126. Merck Typhoid Vaccine Product and Services
Table 127. Merck Typhoid Vaccine SWOT Analysis
Table 128. Merck Recent Developments
Table 129. GlaxoSmithKline Company Information
Table 130. GlaxoSmithKline Description and Overview
Table 131. GlaxoSmithKline Typhoid Vaccine Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 132. GlaxoSmithKline Typhoid Vaccine Product and Services
Table 133. GlaxoSmithKline Typhoid Vaccine SWOT Analysis
Table 134. GlaxoSmithKline Recent Developments
Table 135. PaxVax Company Information
Table 136. PaxVax Description and Overview
Table 137. PaxVax Typhoid Vaccine Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 138. PaxVax Typhoid Vaccine Product and Services
Table 139. PaxVax Typhoid Vaccine SWOT Analysis
Table 140. PaxVax Recent Developments
Table 141. Actiza Pharmaceutical Company Information
Table 142. Actiza Pharmaceutical Description and Overview
Table 143. Actiza Pharmaceutical Typhoid Vaccine Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 144. Actiza Pharmaceutical Typhoid Vaccine Product and Services
Table 145. Actiza Pharmaceutical Typhoid Vaccine SWOT Analysis
Table 146. Actiza Pharmaceutical Recent Developments
Table 147. Merit Pharmaceuticals Company Information
Table 148. Merit Pharmaceuticals Description and Overview
Table 149. Merit Pharmaceuticals Typhoid Vaccine Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 150. Merit Pharmaceuticals Typhoid Vaccine Product and Services
Table 151. Merit Pharmaceuticals Typhoid Vaccine SWOT Analysis
Table 152. Merit Pharmaceuticals Recent Developments
Table 153. Bharat Biotec Company Information
Table 154. Bharat Biotec Description and Overview
Table 155. Bharat Biotec Typhoid Vaccine Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 156. Bharat Biotec Typhoid Vaccine Product and Services
Table 157. Bharat Biotec Typhoid Vaccine SWOT Analysis
Table 158. Bharat Biotec Recent Developments
Table 159. Key Raw Materials Lists
Table 160. Raw Materials Key Suppliers Lists
Table 161. Typhoid Vaccine Distributors List
Table 162. Typhoid Vaccine Customers List
Table 163. Typhoid Vaccine Market Trends
Table 164. Typhoid Vaccine Market Drivers
Table 165. Typhoid Vaccine Market Challenges
Table 166. Typhoid Vaccine Market Restraints
Table 167. Research Programs/Design for This Report
Table 168. Key Data Information from Secondary Sources
Table 169. Key Data Information from Primary Sources
List of Figures
Figure 1. Typhoid Vaccine Product Picture
Figure 2. Global Typhoid Vaccine Market Size Growth Rate by Type, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Typhoid Vaccine Market Share by Type in 2022 & 2034
Figure 4. Oral Type Typhoid Vaccine Product Picture
Figure 5. Injection Type Typhoid Vaccine Product Picture
Figure 6. Global Typhoid Vaccine Market Size Growth Rate by Application, 2018 VS 2022 VS 2034 (US$ Million)
Figure 7. Global Typhoid Vaccine Market Share by Application in 2022 & 2034
Figure 8. Hospital
Figure 9. Research & Academic Laboratories
Figure 10. Pharmaceutical & Biotechnology Companies
Figure 11. Others
Figure 12. Typhoid Vaccine Report Years Considered
Figure 13. Global Typhoid Vaccine Revenue, (US$ Million), 2018 VS 2022 VS 2034
Figure 14. Global Typhoid Vaccine Revenue 2018-2034 (US$ Million)
Figure 15. Global Typhoid Vaccine Revenue Market Share by Region in Percentage: 2022 Versus 2034
Figure 16. Global Typhoid Vaccine Sales Quantity 2018-2034 (K Units)
Figure 17. Global Typhoid Vaccine Sales Quantity Market Share by Region (2018-2024)
Figure 18. Global Typhoid Vaccine Sales Quantity Market Share by Region (2024-2034)
Figure 19. North America Typhoid Vaccine Sales Quantity YoY (2018-2034) & (K Units)
Figure 20. North America Typhoid Vaccine Revenue YoY (2018-2034) & (US$ Million)
Figure 21. Europe Typhoid Vaccine Sales Quantity YoY (2018-2034) & (K Units)
Figure 22. Europe Typhoid Vaccine Revenue YoY (2018-2034) & (US$ Million)
Figure 23. China Typhoid Vaccine Sales Quantity YoY (2018-2034) & (K Units)
Figure 24. China Typhoid Vaccine Revenue YoY (2018-2034) & (US$ Million)
Figure 25. APAC Typhoid Vaccine Sales Quantity YoY (2018-2034) & (K Units)
Figure 26. APAC Typhoid Vaccine Revenue YoY (2018-2034) & (US$ Million)
Figure 27. Middle East, Africa and Latin America Typhoid Vaccine Sales Quantity YoY (2018-2034) & (K Units)
Figure 28. Middle East, Africa and Latin America Typhoid Vaccine Revenue YoY (2018-2034) & (US$ Million)
Figure 29. The Top 10 and Top 5 Players Market Share by Typhoid Vaccine Sales Quantity in 2022
Figure 30. The Top 10 and Top 5 Players Market Share by Typhoid Vaccine Revenue in 2022
Figure 31. Typhoid Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 32. Global Typhoid Vaccine Sales Quantity Market Share by Type (2018-2034)
Figure 33. Global Typhoid Vaccine Revenue Market Share by Type (2018-2034)
Figure 34. Global Typhoid Vaccine Sales Quantity Market Share by Application (2018-2034)
Figure 35. Global Typhoid Vaccine Revenue Market Share by Application (2018-2034)
Figure 36. North America Typhoid Vaccine Revenue Market Share by Company in 2022
Figure 37. North America Typhoid Vaccine Sales Quantity Market Share by Company in 2022
Figure 38. North America Typhoid Vaccine Sales Quantity Market Share by Type (2018-2034)
Figure 39. North America Typhoid Vaccine Revenue Market Share by Type (2018-2034)
Figure 40. North America Typhoid Vaccine Sales Quantity Market Share by Application (2018-2034)
Figure 41. North America Typhoid Vaccine Revenue Market Share by Application (2018-2034)
Figure 42. North America Typhoid Vaccine Revenue Share by Country (2018-2034)
Figure 43. North America Typhoid Vaccine Sales Quantity Share by Country (2018-2034)
Figure 44. U.S. Typhoid Vaccine Revenue (2018-2034) & (US$ Million)
Figure 45. Canada Typhoid Vaccine Revenue (2018-2034) & (US$ Million)
Figure 46. Europe Typhoid Vaccine Sales Quantity Market Share by Company in 2022
Figure 47. Europe Typhoid Vaccine Revenue Market Share by Company in 2022
Figure 48. Europe Typhoid Vaccine Sales Quantity Market Share by Type (2018-2034)
Figure 49. Europe Typhoid Vaccine Revenue Market Share by Type (2018-2034)
Figure 50. Europe Typhoid Vaccine Sales Quantity Market Share by Application (2018-2034)
Figure 51. Europe Typhoid Vaccine Revenue Market Share by Application (2018-2034)
Figure 52. Europe Typhoid Vaccine Revenue Share by Country (2018-2034)
Figure 53. Europe Typhoid Vaccine Sales Quantity Share by Country (2018-2034)
Figure 54. Germany Typhoid Vaccine Revenue (2018-2034) & (US$ Million)
Figure 55. France Typhoid Vaccine Revenue (2018-2034) & (US$ Million)
Figure 56. U.K. Typhoid Vaccine Revenue (2018-2034) & (US$ Million)
Figure 57. Italy Typhoid Vaccine Revenue (2018-2034) & (US$ Million)
Figure 58. Russia Typhoid Vaccine Revenue (2018-2034) & (US$ Million)
Figure 59. China Typhoid Vaccine Sales Quantity Market Share by Company in 2022
Figure 60. China Typhoid Vaccine Revenue Market Share by Company in 2022
Figure 61. China Typhoid Vaccine Sales Quantity Market Share by Type (2018-2034)
Figure 62. China Typhoid Vaccine Revenue Market Share by Type (2018-2034)
Figure 63. China Typhoid Vaccine Sales Quantity Market Share by Application (2018-2034)
Figure 64. China Typhoid Vaccine Revenue Market Share by Application (2018-2034)
Figure 65. APAC Typhoid Vaccine Sales Quantity Market Share by Company in 2022
Figure 66. APAC Typhoid Vaccine Revenue Market Share by Company in 2022
Figure 67. APAC Typhoid Vaccine Sales Quantity Market Share by Type (2018-2034)
Figure 68. APAC Typhoid Vaccine Revenue Market Share by Type (2018-2034)
Figure 69. APAC Typhoid Vaccine Sales Quantity Market Share by Application (2018-2034)
Figure 70. APAC Typhoid Vaccine Revenue Market Share by Application (2018-2034)
Figure 71. APAC Typhoid Vaccine Revenue Share by Region (2018-2034)
Figure 72. APAC Typhoid Vaccine Sales Quantity Share by Region (2018-2034)
Figure 73. Japan Typhoid Vaccine Revenue (2018-2034) & (US$ Million)
Figure 74. South Korea Typhoid Vaccine Revenue (2018-2034) & (US$ Million)
Figure 75. China Taiwan Typhoid Vaccine Revenue (2018-2034) & (US$ Million)
Figure 76. Southeast Asia Typhoid Vaccine Revenue (2018-2034) & (US$ Million)
Figure 77. India Typhoid Vaccine Revenue (2018-2034) & (US$ Million)
Figure 78. Middle East, Africa and Latin America Typhoid Vaccine Sales Quantity Market Share by Company in 2022
Figure 79. Middle East, Africa and Latin America Typhoid Vaccine Revenue Market Share by Company in 2022
Figure 80. Middle East, Africa and Latin America Typhoid Vaccine Sales Quantity Market Share by Type (2018-2034)
Figure 81. Middle East, Africa and Latin America Typhoid Vaccine Revenue Market Share by Type (2018-2034)
Figure 82. Middle East, Africa and Latin America Typhoid Vaccine Sales Quantity Market Share by Application (2018-2034)
Figure 83. Middle East, Africa and Latin America Typhoid Vaccine Revenue Market Share by Application (2018-2034)
Figure 84. Middle East, Africa and Latin America Typhoid Vaccine Sales Quantity Share by Country (2018-2034)
Figure 85. Middle East, Africa and Latin America Typhoid Vaccine Revenue Share by Country (2018-2034)
Figure 86. Brazil Typhoid Vaccine Revenue (2018-2034) & (US$ Million)
Figure 87. Mexico Typhoid Vaccine Revenue (2018-2034) & (US$ Million)
Figure 88. Turkey Typhoid Vaccine Revenue (2018-2034) & (US$ Million)
Figure 89. Israel Typhoid Vaccine Revenue (2018-2034) & (US$ Million)
Figure 90. GCC Countries Typhoid Vaccine Revenue (2018-2034) & (US$ Million)
Figure 91. Typhoid Vaccine Value Chain
Figure 92. Typhoid Vaccine Production Process
Figure 93. Channels of Distribution (Direct Vs Distribution)
Figure 94. Distributors Profiles
Figure 95. Bottom-up and Top-down Approaches for This Report
Figure 96. Data Triangulation
Figure 97. Key Executives Interviewed